FRnet-DTI: Deep Convolutional Neural Networks with Evolutionary and Structural Features for Drug-Target Interaction
Authors:
Farshid Rayhan,
Sajid Ahmed,
Zaynab Mousavian,
Dewan Md Farid,
Swakkhar Shatabda
Abstract:
The task of drug-target interaction prediction holds significant importance in pharmacology and therapeutic drug design. In this paper, we present FRnet-DTI, an auto encoder and a convolutional classifier for feature manipulation and drug target interaction prediction. Two convolutional neural neworks are proposed where one model is used for feature manipulation and the other one for classificatio…
▽ More
The task of drug-target interaction prediction holds significant importance in pharmacology and therapeutic drug design. In this paper, we present FRnet-DTI, an auto encoder and a convolutional classifier for feature manipulation and drug target interaction prediction. Two convolutional neural neworks are proposed where one model is used for feature manipulation and the other one for classification. Using the first method FRnet-1, we generate 4096 features for each of the instances in each of the datasets and use the second method, FRnet-2, to identify interaction probability employing those features. We have tested our method on four gold standard datasets exhaustively used by other researchers. Experimental results shows that our method significantly improves over the state-of-the-art method on three of the four drug-target interaction gold standard datasets on both area under curve for Receiver Operating Characteristic(auROC) and area under Precision Recall curve(auPR) metric. We also introduce twenty new potential drug-target pairs for interaction based on high prediction scores. Codes Available: https: // github. com/ farshidrayhanuiu/ FRnet-DTI/ Web Implementation: http: // farshidrayhan. pythonanywhere. com/ FRnet-DTI/
△ Less
Submitted 31 August, 2018; v1 submitted 19 June, 2018;
originally announced June 2018.
iDTI-ESBoost: Identification of Drug Target Interaction Using Evolutionary and Structural Features with Boosting
Authors:
Farshid Rayhan,
Sajid Ahmed,
Swakkhar Shatabda,
Dewan Md Farid,
Zaynab Mousavian,
Abdollah Dehzangi,
M Sohel Rahman
Abstract:
Prediction of new drug-target interactions is extremely important as it can lead the researchers to find new uses for old drugs and to realize the therapeutic profiles or side effects thereof. However, experimental prediction of drug-target interactions is expensive and time-consuming. As a result, computational methods for prediction of new drug-target interactions have gained much interest in re…
▽ More
Prediction of new drug-target interactions is extremely important as it can lead the researchers to find new uses for old drugs and to realize the therapeutic profiles or side effects thereof. However, experimental prediction of drug-target interactions is expensive and time-consuming. As a result, computational methods for prediction of new drug-target interactions have gained much interest in recent times. We present iDTI-ESBoost, a prediction model for identification of drug-target interactions using evolutionary and structural features. Our proposed method uses a novel balancing technique and a boosting technique for the binary classification problem of drug-target interaction. On four benchmark datasets taken from a gold standard data, iDTI-ESBoost outperforms the state-of-the-art methods in terms of area under Receiver operating characteristic (auROC) curve. iDTI-ESBoost also outperforms the latest and the best-performing method in the literature to-date in terms of area under precision recall (auPR) curve. This is significant as auPR curves are argued to be more appropriate as a metric for comparison for imbalanced datasets, like the one studied in this research. In the sequel, our experiments establish the effectiveness of the classifier, balancing methods and the novel features incorporated in iDTI-ESBoost. iDTI-ESBoost is a novel prediction method that has for the first time exploited the structural features along with the evolutionary features to predict drug-protein interactions. We believe the excellent performance of iDTI-ESBoost both in terms of auROC and auPR would motivate the researchers and practitioners to use it to predict drug-target interactions. To facilitate that, iDTI-ESBoost is readily available for use at: http://farshidrayhan.pythonanywhere.com/iDTI-ESBoost/
△ Less
Submitted 4 July, 2017;
originally announced July 2017.
